April 25, 2019
For Immediate Release
Mayor Solomon, Council President Merolla, & Ortho RI Break Ground on new medical office and surgery center Facility part of Carpionato’s bio-medical destination campus at Crossings Office Park
WARWICK, RHODE ISLAND –Mayor Joseph J. Solomon and Council President Steven Merolla joined with shareholders of Ortho Rhode Island, Calspan and Carpionato Group today to break ground on a new state-of-the art medical office and surgery center for Ortho Rhode Island at the Crossings Office Park. The project will be done in two phases with the first being a 60,000 square foot building, a second 40,000 square foot building will be built later. The site is also the home to the worldwide headquarters of the Davol division of BD – which has a 120,000 square foot biotechnology research and development facility located there as well.
“I am extremely pleased to see my husband, Alfred Carpionato’s vision for a bio-medical destination campus at the Crossings Office Park come to fruition,” said Sheryl Carpionato, a trustee of Carpionato Group. “My husband believed this site, at the intersection of Interstate highways, the airport and train station was a prime location for smart economic development, and we are confident this is just the beginning of an ever expanding bio-medical campus in Warwick.”
“The Carpionato Group has been a very significant and successful part of our business community for decades, and I thank them for their continued investment in our City,” said Warwick Mayor Joseph J. Solomon. “I am very excited to see this project moving forward, not only for the City, but also for the legacy of Alfred Carpionato’s vision for a better community. It will bring good paying jobs to our City, will provide the cornerstone of this bio-medical destination campus and continue the momentum we’ve built to bring quality economic development projects to Warwick.”
“This project would not be possible without the support of Mayor Solomon and Council President Merolla,” said Dr. Michael P. Bradley, President and CEO of Ortho RI. “The support we have received from the City has made it very easy for us to make this significant investment in Warwick as we build this world-class, highly innovative and high-tech facility for the future.”
The project will create 125 construction jobs and bring more than 275 permanent bio-medical jobs to the site with a total annual payroll of $30,000,000. The new facility will add more than $25-million in assessed value to the City of Warwick tax rolls.
“Warwick will have a very significant economic development driver when this project is completed,” said Council President Steve Merolla.“OrthoRI is on the cutting edge of medicine, and its expansion at the Crossings Office Park will be a draw for other complementary biomedical companies seeking synergies and convenience in one location.”
The project will be executed by Calspan Development & Construction. “We are thrilled to be able to provide a world class facility to the world class physicians and medical professionals at Ortho Rhode Island,” stated John Yurtchuk, President and Chief Executive Officer of Calspan Development & Construction.
About Carpionato Group
Carpionato Group is a leading New England real estate development company that delivers a platform of integrated real estate professions providing distinguished expertise in their fields. The breadth of experience extends to public & private partnerships, joint ventures, leasing, brokerage, acquisitions, tenant representation, marketing, construction and property management. With a portfolio of over Six Million square feet of real estate assets comprised of Class A Retail, Office, Residential and Hospitality products and a $1.5 Billion Dollar development project pipeline, Carpionato Group’s vision and growth has unwavering momentum. Our focus for expansion is New England.
Gregg Perry, Carpionato Group 401-331-4600(o)/401-338-5076(m)
Courtney Marciano – City of Warwick 401-738-2000 x-9655
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE